Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Increased HLA-G Expression in Term Placenta of Women with a History of Recurrent Miscarriage Despite Their Genetic Predisposition to Decreased HLA-G Levels.

Craenmehr MHC, Nederlof I, Cao M, Drabbels JJM, Spruyt-Gerritse MJ, Anholts JDH, Kapsenberg HM, Stegehuis JA, van der Keur C, Fasse E, Haasnoot GW, van der Hoorn MP, Claas FHJ, Heidt S, Eikmans M.

Int J Mol Sci. 2019 Feb 1;20(3). pii: E625. doi: 10.3390/ijms20030625.

2.

The long and winding road towards epitope matching in clinical transplantation.

Kramer CSM, Israeli M, Mulder A, Doxiadis IIN, Haasnoot GW, Heidt S, Claas FHJ.

Transpl Int. 2019 Jan;32(1):16-24. doi: 10.1111/tri.13362. Epub 2018 Nov 26. Review.

PMID:
30341790
3.

Exposure to non-inherited maternal antigens by breastfeeding affects antibody responsiveness.

Schonewille H, van Rood JJ, Verduin EP, van de Watering LMG, Haasnoot GW, Claas FHJ, Oepkes D, Lopriore E, Brand A.

Haematologica. 2019 Feb;104(2):263-268. doi: 10.3324/haematol.2018.199406. Epub 2018 Sep 13.

4.

The combination of maternal KIR-B and fetal HLA-C2 is associated with decidua basalis acute atherosis in pregnancies with preeclampsia.

Johnsen GM, Størvold GL, Drabbels JJM, Haasnoot GW, Eikmans M, Spruyt-Gerritse MJ, Alnæs-Katjavivi P, Scherjon SA, Redman CWG, Claas FHJ, Staff AC.

J Reprod Immunol. 2018 Sep;129:23-29. doi: 10.1016/j.jri.2018.07.005. Epub 2018 Jul 25.

PMID:
30055414
5.

Reduced Risk of BK Polyomavirus Infection in HLA-B51 Positive Kidney Transplant Recipients.

Wunderink HF, Haasnoot GW, de Brouwer CS, van Zwet EW, Kroes ACM, de Fijter JW, Rotmans JI, Claas FHJ, Feltkamp MCW.

Transplantation. 2018 Jul 25. doi: 10.1097/TP.0000000000002376. [Epub ahead of print]

PMID:
30048396
6.

How the definition of acceptable antigens and epitope analysis can facilitate transplantation of highly sensitized patients with excellent long-term graft survival.

Heidt S, Haasnoot GW, Claas FHJ.

Curr Opin Organ Transplant. 2018 Aug;23(4):493-499. doi: 10.1097/MOT.0000000000000545.

PMID:
29846197
7.

Maternal and child human leukocyte antigens in congenital cytomegalovirus infection.

Rovito R, Claas FHJ, Haasnoot GW, Roelen DL, Kroes ACM, Vossen ACTM.

J Reprod Immunol. 2018 Apr;126:39-45. doi: 10.1016/j.jri.2018.01.002. Epub 2018 Jan 31.

8.

Elevated intragraft expression of innate immunity and cell death-related markers is a risk factor for adverse graft outcome.

Yang J, Snijders MLH, Haasnoot GW, van Kooten C, Mallat M, de Fijter JW, Clahsen-van Groningen MC, Claas FHJ, Eikmans M.

Transpl Immunol. 2018 Jun;48:39-46. doi: 10.1016/j.trim.2018.02.009. Epub 2018 Feb 20.

PMID:
29475090
9.

Congenital Cytomegalovirus Infection: Maternal-Child HLA-C, HLA-E, and HLA-G Affect Clinical Outcome.

Rovito R, Claas FHJ, Haasnoot GW, Roelen DL, Kroes ACM, Eikmans M, Vossen ACTM.

Front Immunol. 2018 Jan 5;8:1904. doi: 10.3389/fimmu.2017.01904. eCollection 2017.

10.

Paternal HLA-C is a risk factor in unexplained recurrent miscarriage.

Meuleman T, Haasnoot GW, van Lith JMM, Verduijn W, Bloemenkamp KWM, Claas FHJ.

Am J Reprod Immunol. 2018 Feb;79(2). doi: 10.1111/aji.12797. Epub 2017 Dec 4.

PMID:
29205643
11.

Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity.

Meysman P, De Neuter N, Bartholomeus E, Elias G, Van den Bergh J, Emonds MP, Haasnoot GW, Heynderickx S, Wens J, Michels NR, Lambert J, Lion E, Claas FHJ, Goossens H, Smits E, Van Damme P, Van Tendeloo V, Beutels P, Suls A, Mortier G, Laukens K, Ogunjimi B.

Immunogenetics. 2018 Jun;70(6):363-372. doi: 10.1007/s00251-017-1047-x. Epub 2017 Dec 1.

PMID:
29196796
12.

Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.

Heidt S, Haasnoot GW, van Rood JJ, Witvliet MD, Claas FHJ.

Kidney Int. 2018 Feb;93(2):491-500. doi: 10.1016/j.kint.2017.07.018. Epub 2017 Sep 22.

PMID:
28947279
13.

Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4.

van Sonderen A, Roelen DL, Stoop JA, Verdijk RM, Haasnoot GW, Thijs RD, Wirtz PW, Schreurs MW, Claas FH, Sillevis Smitt PA, Titulaer MJ.

Ann Neurol. 2017 Feb;81(2):193-198. doi: 10.1002/ana.24858. Epub 2017 Jan 27.

PMID:
28026046
14.

Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.

Wunderink HF, van der Meijden E, van der Blij-de Brouwer CS, Mallat MJ, Haasnoot GW, van Zwet EW, Claas EC, de Fijter JW, Kroes AC, Arnold F, Touzé A, Claas FH, Rotmans JI, Feltkamp MC.

Am J Transplant. 2017 Jan;17(1):161-172. doi: 10.1111/ajt.13880. Epub 2016 Jul 8.

15.

The 25th anniversary of the Eurotransplant Acceptable Mismatch program for highly sensitized patients.

Heidt S, Witvliet MD, Haasnoot GW, Claas FH.

Transpl Immunol. 2015 Oct;33(2):51-7. doi: 10.1016/j.trim.2015.08.006. Epub 2015 Aug 29.

PMID:
26325207
16.

Selective advantage of HLA matching in successful uncomplicated oocyte donation pregnancies.

Lashley LE, Haasnoot GW, Spruyt-Gerritse M, Claas FH.

J Reprod Immunol. 2015 Nov;112:29-33. doi: 10.1016/j.jri.2015.05.006. Epub 2015 Jun 23.

PMID:
26232147
17.

A role for KMT1c in monocyte to dendritic cell differentiation: Epigenetic regulation of monocyte differentiation.

Wierda RJ, Goedhart M, van Eggermond MC, Muggen AF, Miggelbrink XM, Geutskens SB, van Zwet E, Haasnoot GW, van den Elsen PJ.

Hum Immunol. 2015 Jun;76(6):431-7. doi: 10.1016/j.humimm.2015.03.017. Epub 2015 Apr 3.

PMID:
25843229
18.

Skewed expression of the genes encoding epigenetic modifiers in high-risk uveal melanoma.

Herlihy N, Dogrusöz M, van Essen TH, Harbour JW, van der Velden PA, van Eggermond MC, Haasnoot GW, van den Elsen PJ, Jager MJ.

Invest Ophthalmol Vis Sci. 2015 Jan 15;56(3):1447-58. doi: 10.1167/iovs.14-15250.

19.

Association between CTL Precursor Frequency to HLA-C Mismatches and HLA-C Antigen Cell Surface Expression.

Israeli M, Roelen DL, Carrington M, Petersdorf EW, Claas FH, Haasnoot GW, Oudshoorn M.

Front Immunol. 2014 Oct 27;5:547. doi: 10.3389/fimmu.2014.00547. eCollection 2014.

20.

Maternal HLA-C2 and 14 bp insertion in HLA-G is associated with recurrent implantation failure after in vitro fertilization treatment.

Lashley LE, van der Westerlaken LA, Haasnoot GW, Drabbels JJ, Spruyt-Gerritse MJ, Scherjon SA, Claas FH.

Tissue Antigens. 2014 Dec;84(6):536-44. doi: 10.1111/tan.12452. Epub 2014 Nov 4.

PMID:
25367742
21.

HLA dosage effect in narcolepsy with cataplexy.

van der Heide A, Verduijn W, Haasnoot GW, Drabbels JJ, Lammers GJ, Claas FH.

Immunogenetics. 2015 Jan;67(1):1-6. doi: 10.1007/s00251-014-0808-z. Epub 2014 Oct 3.

PMID:
25277311
22.

Age-dependent HLA profiles of the Israeli population: impact on hematopoietic cell donor recruitment and availability.

Israeli M, Oudshoorn M, Haasnoot GW, Klein T, Zisser B, Bach G, Claas FH.

Immunogenetics. 2014 Oct;66(9-10):525-33.

PMID:
25015021
23.

Uncomplicated oocyte donation pregnancies are associated with a higher incidence of human leukocyte antigen alloantibodies.

Lashley LE, van der Hoorn ML, Haasnoot GW, Roelen DL, Claas FH.

Hum Immunol. 2014 Jun;75(6):555-60. doi: 10.1016/j.humimm.2014.02.016. Epub 2014 Feb 12.

PMID:
24530746
24.

Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable.

Laging M, Kal-van Gestel JA, Haasnoot GW, Claas FH, van de Wetering J, Ijzermans JN, Weimar W, Roodnat JI.

Transplantation. 2014 Feb 15;97(3):330-6. doi: 10.1097/01.TP.0000435703.61642.43.

PMID:
24202143
25.

Increased metallothionein expression reflects steroid resistance in renal allograft recipients.

Rekers NV, Bajema IM, Mallat MJ, Anholts JD, de Vaal YJ, Zandbergen M, Haasnoot GW, van Zwet EW, de Fijter JW, Claas FH, Eikmans M.

Am J Transplant. 2013 Aug;13(8):2106-18. doi: 10.1111/ajt.12314. Epub 2013 Jun 13.

26.

Relation between HLA genes, human skin volatiles and attractiveness of humans to malaria mosquitoes.

Verhulst NO, Beijleveld H, Qiu YT, Maliepaard C, Verduyn W, Haasnoot GW, Claas FH, Mumm R, Bouwmeester HJ, Takken W, van Loon JJ, Smallegange RC.

Infect Genet Evol. 2013 Aug;18:87-93. doi: 10.1016/j.meegid.2013.05.009. Epub 2013 May 18.

27.

The impact of frequent HLA haplotypes in high linkage disequilibrium on donor search and clinical outcome after unrelated haematopoietic SCT.

Jöris MM, Lankester AC, von dem Borne PA, Kuball J, Bierings M, Cornelissen JJ, Groenendijk-Sijnke ME, van der Holt B, Haasnoot GW, van der Zanden HG, van Walraven SM, van Rood JJ, Claas FH, Oudshoorn M.

Bone Marrow Transplant. 2013 Apr;48(4):483-90. doi: 10.1038/bmt.2012.189. Epub 2012 Oct 15.

PMID:
23064039
28.

High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.

Verduin EP, Schonewille H, Brand A, Haasnoot GW, Claas FH, Lindenburg IT, Lopriore E, Oepkes D, Roelen DL, Doxiadis II.

Transfusion. 2013 May;53(5):939-47. doi: 10.1111/j.1537-2995.2012.03862.x. Epub 2012 Aug 23.

PMID:
22924899
29.

Quantitative polymerase chain reaction profiling of immunomarkers in rejecting kidney allografts for predicting response to steroid treatment.

Rekers NV, Bajema IM, Mallat MJ, Zuidwijk K, Anholts JD, Goemaere N, Haasnoot GW, van Groningen MC, van Kooten C, de Fijter JW, Claas FH, Eikmans M.

Transplantation. 2012 Sep 27;94(6):596-602.

PMID:
22902790
30.

The functional polymorphism Ala258Ser in the innate receptor gene ficolin-2 in the donor predicts improved renal transplant outcome.

Eikmans M, de Canck I, van der Pol P, Baan CC, Haasnoot GW, Mallat MJ, Vergunst M, de Meester E, Roodnat JI, Anholts JD, van Thielen M, Doxiadis II, de Fijter JW, van der Linden PJ, van Beelen E, van Kooten C, Kal-van Gestel JA, Peeters AM, Weimar W, Roelen DL, Rossau R, Claas FH.

Transplantation. 2012 Sep 15;94(5):478-85.

PMID:
22892990
31.

Genetic HLA associations in complex regional pain syndrome with and without dystonia.

van Rooijen DE, Roelen DL, Verduijn W, Haasnoot GW, Huygen FJ, Perez RS, Claas FH, Marinus J, van Hilten JJ, van den Maagdenberg AM.

J Pain. 2012 Aug;13(8):784-9. doi: 10.1016/j.jpain.2012.05.003. Epub 2012 Jul 12.

PMID:
22795247
32.

The risk of cancer is not increased in patients with multiple kidney transplantations.

Wisgerhof HC, Wolterbeek R, Haasnoot GW, Claas FH, de Fijter JW, Willemze R, Bouwes Bavinck JN.

Transpl Immunol. 2012 Dec;27(4):189-94. doi: 10.1016/j.trim.2012.06.002. Epub 2012 Jun 15.

PMID:
22709939
33.

Composition of human skin microbiota affects attractiveness to malaria mosquitoes.

Verhulst NO, Qiu YT, Beijleveld H, Maliepaard C, Knights D, Schulz S, Berg-Lyons D, Lauber CL, Verduijn W, Haasnoot GW, Mumm R, Bouwmeester HJ, Claas FH, Dicke M, van Loon JJ, Takken W, Knight R, Smallegange RC.

PLoS One. 2011;6(12):e28991. doi: 10.1371/journal.pone.0028991. Epub 2011 Dec 28.

34.

KIR-ligand mismatches are associated with reduced long-term graft survival in HLA-compatible kidney transplantation.

van Bergen J, Thompson A, Haasnoot GW, Roodnat JI, de Fijter JW, Claas FH, Koning F, Doxiadis II.

Am J Transplant. 2011 Sep;11(9):1959-64. doi: 10.1111/j.1600-6143.2011.03621.x. Epub 2011 Jun 30.

35.

Incidence of cancer in kidney-transplant recipients: a long-term cohort study in a single center.

Wisgerhof HC, van der Geest LG, de Fijter JW, Haasnoot GW, Claas FH, le Cessie S, Willemze R, Bouwes Bavinck JN.

Cancer Epidemiol. 2011 Apr;35(2):105-11. doi: 10.1016/j.canep.2010.07.002. Epub 2010 Jul 31.

PMID:
20674538
36.

The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth.

Nielsen HS, Witvliet MD, Steffensen R, Haasnoot GW, Goulmy E, Christiansen OB, Claas F.

J Reprod Immunol. 2010 Dec;87(1-2):67-73. doi: 10.1016/j.jri.2010.05.006. Erratum in: J Reprod Immunol. 2011 May;89(2):216.

PMID:
20605049
37.

HLA-DQ2+ individuals are susceptible to Hu-Ab associated paraneoplastic neurological syndromes.

de Graaf MT, de Beukelaar JW, Haasnoot GW, Levering WH, Rogemond V, Didelot A, Honnorat J, Gratama JW, Smitt PA.

J Neuroimmunol. 2010 Sep 14;226(1-2):147-9. doi: 10.1016/j.jneuroim.2010.05.035. Epub 2010 Jun 12.

PMID:
20547426
38.

Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors.

Wisgerhof HC, Edelbroek JR, de Fijter JW, Haasnoot GW, Claas FH, Willemze R, Bavinck JN.

Transplantation. 2010 May 27;89(10):1231-8. doi: 10.1097/TP.0b013e3181d84cdc.

PMID:
20410852
39.

Human monoclonal HLA antibodies reveal interspecies crossreactive swine MHC class I epitopes relevant for xenotransplantation.

Mulder A, Kardol MJ, Arn JS, Eijsink C, Franke ME, Schreuder GM, Haasnoot GW, Doxiadis II, Sachs DH, Smith DM, Claas FH.

Mol Immunol. 2010 Jan;47(4):809-15. doi: 10.1016/j.molimm.2009.10.004. Epub 2009 Nov 22.

PMID:
19931911
40.

Regional kidney allocation based only on full HLA-DR compatibility is not feasible.

Heemskerk MB, Haase-Kromwijk BJ, Claas FH, Doxiadis II, Haasnoot GW, Homan van der Heide JJ, Weimar WW, Hoitsma AJ.

Transplantation. 2009 Aug 27;88(4):600-1. doi: 10.1097/TP.0b013e3181b16174. No abstract available.

PMID:
19696649
41.

HLA-B8, DR3: a new risk factor for graft failure after renal transplantation in patients with underlying immunoglobulin A nephropathy.

Andresdottir MB, Haasnoot GW, Persijn GG, Claas FH.

Clin Transplant. 2009 Sep-Oct;23(5):660-5. doi: 10.1111/j.1399-0012.2009.01059.x. Epub 2009 Aug 11.

PMID:
19674013
42.

Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells.

Tilburgs T, Scherjon SA, van der Mast BJ, Haasnoot GW, Versteeg-V D Voort-Maarschalk M, Roelen DL, van Rood JJ, Claas FH.

J Reprod Immunol. 2009 Nov;82(2):148-57. doi: 10.1016/j.jri.2009.05.003. Epub 2009 Jul 23.

PMID:
19631389
43.

Increased risk of squamous-cell carcinoma in simultaneous pancreas kidney transplant recipients compared with kidney transplant recipients.

Wisgerhof HC, van der Boog PJ, de Fijter JW, Wolterbeek R, Haasnoot GW, Claas FH, Willemze R, Bouwes Bavinck JN.

J Invest Dermatol. 2009 Dec;129(12):2886-94. doi: 10.1038/jid.2009.181. Epub 2009 Jul 2.

44.

HLA-B62 and HLA-DQ8 are associated with Complex Regional Pain Syndrome with fixed dystonia.

de Rooij AM, Florencia Gosso M, Haasnoot GW, Marinus J, Verduijn W, Claas FH, van den Maagdenberg AM, van Hilten JJ.

Pain. 2009 Sep;145(1-2):82-5. doi: 10.1016/j.pain.2009.05.015. Epub 2009 Jun 11.

PMID:
19523767
45.

The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma.

Helgadottir H, Andersson E, Villabona L, Kanter L, van der Zanden H, Haasnoot GW, Seliger B, Bergfeldt K, Hansson J, Ragnarsson-Olding B, Kiessling R, Masucci GV.

Cancer Immunol Immunother. 2009 Oct;58(10):1599-608. doi: 10.1007/s00262-009-0669-8. Epub 2009 Feb 13.

PMID:
19214504
46.

Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer.

Gamzatova Z, Villabona L, van der Zanden H, Haasnoot GW, Andersson E, Kiessling R, Seliger B, Kanter L, Dalianis T, Bergfeldt K, Masucci GV.

Tissue Antigens. 2007 Sep;70(3):205-13.

PMID:
17661908
47.

Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility.

Doxiadis II, de Fijter JW, Mallat MJ, Haasnoot GW, Ringers J, Persijn GG, Claas FH.

Transplantation. 2007 May 15;83(9):1207-13.

PMID:
17496537
48.

Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5.

Niks EH, Kuks JB, Roep BO, Haasnoot GW, Verduijn W, Ballieux BE, De Baets MH, Vincent A, Verschuuren JJ.

Neurology. 2006 Jun 13;66(11):1772-4.

PMID:
16769963
49.

The relationship between HLA class II polymorphisms and somatic deletions in testicular B cell lymphomas of Dutch patients.

Riemersma SA, Jordanova ES, Haasnoot GW, Drabbels J, Schuuring E, Schreuder GM, Kluin PM.

Hum Immunol. 2006 Apr-May;67(4-5):303-10. Epub 2006 Apr 7.

PMID:
16720210
50.

HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.

Maat W, Haasnoot GW, Claas FH, Schalij-Delfos NE, Schreuder GM, Jager MJ.

Invest Ophthalmol Vis Sci. 2006 Jan;47(1):3-6.

PMID:
16384937

Supplemental Content

Loading ...
Support Center